In December of 1998, a presentation outlined the discovery, identification and investigation of tNOX (ENOX2). Dr. D. James and Dr. Dorothy M. Morre presented at the American Cell Biology Conference the discovery of tNOX (ENOX2), a tumor associated protein.
CAPSOL-T is formulated with powerful quinine site inhibitors that have been found to block tNOX (ENOX2) proteins. Thus, in trials it seems to interferes with the ability of cancer cells to enlarge to the size required for cell division. CAPSOL-T is a product that consists of food grade decaffeinated green tea concentrate and capsicum powder in an OPTIMUM ratio providing an approximately 100-fold synergy compared to green tea alone.
A Food Based Dietary Supplement: 180 Gelatin Capsules per bottle
Capsol-T is not intended to diagnose, cure, treat or replace medical treatment for any disease and has not been evaluated by the FDA.